{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:25:24Z","timestamp":1740108324916,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Region of Southern Denmark","award":["17\/18517"],"award-info":[{"award-number":["17\/18517"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00228-018-2494-5","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T04:34:30Z","timestamp":1527741270000},"page":"1175-1180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hormonal contraception is not associated with increased risk for seizures in the general population: results from a cohort study using The Health Improvement Network"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8268-1492","authenticated-orcid":false,"given":"Christoph Patrick","family":"Beier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis A.","family":"Garc\u00eda Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda E.","family":"S\u00e1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gaist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Gonz\u00e1lez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,31]]},"reference":[{"key":"2494_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.seizure.2015.02.024","volume":"28","author":"AG Herzog","year":"2015","unstructured":"Herzog AG (2015) Catamenial epilepsy: update on prevalence, pathophysiology and treatment from the findings of the NIH Progesterone Treatment Trial. Seizure 28:18\u201325. \n                    https:\/\/doi.org\/10.1016\/j.seizure.2015.02.024","journal-title":"Seizure"},{"issue":"2","key":"2494_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.yhbeh.2012.03.018","volume":"63","author":"J Veliskova","year":"2013","unstructured":"Veliskova J, Desantis KA (2013) Sex and hormonal influences on seizures and epilepsy. Horm Behav 63(2):267\u2013277. \n                    https:\/\/doi.org\/10.1016\/j.yhbeh.2012.03.018","journal-title":"Horm Behav"},{"key":"2494_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.seizure.2015.02.012","volume":"28","author":"E Taub\u00f8ll","year":"2015","unstructured":"Taub\u00f8ll E, Sveberg L, Svalheim S (2015) Interactions between hormones and epilepsy. Seizure 28:3\u201311. \n                    https:\/\/doi.org\/10.1016\/j.seizure.2015.02.012","journal-title":"Seizure"},{"issue":"2","key":"2494_CR4","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.3949\/ccjm.71.Suppl_2.S4","volume":"71","author":"SS Smith","year":"2004","unstructured":"Smith SS, Woolley CS (2004) Cellular and molecular effects of steroid hormones on CNS excitability. Cleve Clin J Med 71(2):S4","journal-title":"Cleve Clin J Med"},{"issue":"5","key":"2494_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","volume":"20","author":"W L\u00f6scher","year":"2011","unstructured":"L\u00f6scher W (2011) Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure 20(5):359\u2013368. \n                    https:\/\/doi.org\/10.1016\/j.seizure.2011.01.003","journal-title":"Seizure"},{"key":"2494_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.eplepsyres.2016.01.007","volume":"121","author":"I Younus","year":"2016","unstructured":"Younus I, Reddy DS (2016) Seizure facilitating activity of the oral contraceptive ethinyl estradiol. Epilepsy Res 121:29\u201332. \n                    https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.01.007","journal-title":"Epilepsy Res"},{"key":"2494_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/ana.25008","volume":"82","author":"ES Rosenthal","year":"2017","unstructured":"Rosenthal ES, Claassen J, Wainwright MS, Husain AM, Vaitkevicius H, Raines S, Hoffmann E, Colquhoun H, Doherty JJ, Kanes SJ (2017) Brexanolone as adjunctive therapy in super-refractory status epilepticus. Ann Neurol 82:342\u2013352. \n                    https:\/\/doi.org\/10.1002\/ana.25008","journal-title":"Ann Neurol"},{"issue":"24","key":"2494_CR8","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1212\/WNL.0b013e318259e1f9","volume":"78","author":"AG Herzog","year":"2012","unstructured":"Herzog AG, Fowler KM, Smithson SD, Kalayjian LA, Heck CN, Sperling MR, Liporace JD, Harden CL, Dworetzky BA, Pennell PB, Massaro JM (2012) Progesterone vs placebo therapy for women with epilepsy: a randomized clinical trial. Neurology 78(24):1959\u20131966. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e318259e1f9","journal-title":"Neurology"},{"key":"2494_CR9","doi-asserted-by":"publisher","unstructured":"Vessey M, Painter R, Yeates D (2002) Oral contraception and epilepsy: findings in a large cohort study\u2606 \u2606The Oxford-FPA study is funded by a grant from the Medical Research Council. Contraception 66 (2):77\u201379. \n                    https:\/\/doi.org\/10.1016\/S0010-7824(02)00323-2","DOI":"10.1016\/S0010-7824(02)00323-2"},{"key":"2494_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.yebeh.2016.04.020","volume":"60","author":"AG Herzog","year":"2016","unstructured":"Herzog AG, Mandle HB, Cahill KE, Fowler KM, Hauser WA (2016) Differential impact of contraceptive methods on seizures varies by antiepileptic drug category: findings of the Epilepsy Birth Control Registry. Epilepsy Behav 60:112\u2013117. \n                    https:\/\/doi.org\/10.1016\/j.yebeh.2016.04.020","journal-title":"Epilepsy Behav"},{"issue":"1","key":"2494_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.beem.2012.11.004","volume":"27","author":"S Christin-Maitre","year":"2013","unstructured":"Christin-Maitre S (2013) History of oral contraceptive drugs and their use worldwide. Best Pract Res Clin Endocrinol Metab 27(1):3\u201312. \n                    https:\/\/doi.org\/10.1016\/j.beem.2012.11.004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"2494_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/pds.1335","volume":"16","author":"JD Lewis","year":"2007","unstructured":"Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL (2007) Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 16(4):393\u2013401. \n                    https:\/\/doi.org\/10.1002\/pds.1335","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2494_CR13","unstructured":"Stuart-Buttle CD, Read JD, Sanderson HF, Sutton YM (1996) A language of health in action: read codes, classifications and groupings. Proc AMIA Annu Fall Symp:75\u201379"},{"key":"2494_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.yebeh.2016.06.039","volume":"62","author":"ME Saez","year":"2016","unstructured":"Saez ME, Gonzalez-Perez A, Gaist D, Johansson S, Nagy P, Garcia Rodriguez LA (2016) Risk of seizure associated with use of acid-suppressive drugs: an observational cohort study. Epilepsy Behav 62:72\u201380. \n                    https:\/\/doi.org\/10.1016\/j.yebeh.2016.06.039","journal-title":"Epilepsy Behav"},{"key":"2494_CR15","unstructured":"Lader D, Steel M (2009) Opinions survey report no. 41. Office for National Statistics,"},{"issue":"1","key":"2494_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/1471-0528.12465","volume":"121","author":"L Cea-Soriano","year":"2014","unstructured":"Cea-Soriano L, Garc\u00eda Rodr\u00edguez LA, Machlitt A, Wallander MA (2014) Use of prescription contraceptive methods in the UK general population: a primary care study. BJOG Int J Obstet Gynaecol 121(1):53\u201361. \n                    https:\/\/doi.org\/10.1111\/1471-0528.12465","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"9","key":"2494_CR17","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/j.1528-1167.2006.00507.x","volume":"47","author":"CL Harden","year":"2006","unstructured":"Harden CL, Herzog AG, Nikolov BG, Koppel BS, Christos PJ, Fowler K, Labar DR, Hauser WA (2006) Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study. Epilepsia 47(9):1447\u20131451. \n                    https:\/\/doi.org\/10.1111\/j.1528-1167.2006.00507.x","journal-title":"Epilepsia"},{"issue":"17","key":"2494_CR18","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1007\/s00213-014-3539-9","volume":"231","author":"F Santoru","year":"2014","unstructured":"Santoru F, Berretti R, Locci A, Porcu P, Concas A (2014) Decreased allopregnanolone induced by hormonal contraceptives is associated with a reduction in social behavior and sexual motivation in female rats. Psychopharmacology 231(17):3351\u20133364. \n                    https:\/\/doi.org\/10.1007\/s00213-014-3539-9","journal-title":"Psychopharmacology"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-018-2494-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2494-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2494-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T21:41:22Z","timestamp":1559252482000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-018-2494-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,31]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["2494"],"URL":"https:\/\/doi.org\/10.1007\/s00228-018-2494-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2018,5,31]]},"assertion":[{"value":"9 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Beier has also served as an advisory board member for UCB and EISAI and received speaker honoraries from UCB, EISAI, and the Danish Epilepsy Association and research support from UCB, EISAI, Novartis, and Pfizer. Dr. Gaist reported receiving honoraria from AstraZeneca (Sweden) for participation as a coinvestigator on a research project. Dr. Garc\u00eda Rodr\u00edguez, Dr. Gonz\u00e1lez-P\u00e9rez, and Dr. S\u00e1ez work at CEIFE, which has received research grants from Bayer Pharma AG (Germany) and AstraZeneca (Sweden). Dr. Garc\u00eda Rodr\u00edguez has also served as an advisory board member for Bayer Pharma AG (Germany).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}